Ferrous asparto glycinate

Identification

Generic Name

Ferrous asparto glycinate

DrugBank Accession Number

DB11169

Background

Ferrous asparto glycinate is an iron-amino acid chelate. It is available as a dietary supplement used in the treatment of iron deficiency and iron deficiency anemia.

Type

Small Molecule

Groups

Approved

Synonyms

Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

No interactions found.

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Active Moieties

Name	Kind	UNII	CAS	InChI Key
Iron	unknown	E1UOL152H7	7439-89-6	XEEYBQQBJWHFJM-UHFFFAOYSA-N
Ferrous cation	ionic	GW89581OWR	15438-31-0	CWYNVVGOOAEACU-UHFFFAOYSA-N

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Cavan One	Ferrous asparto glycinate (7 mg/1) + Calcium (150 mg/1) + Calcium ascorbate dihydrate (25 mg/1) + Cholecalciferol (170 [iU]/1) + DL-alpha tocopheryl acetate (30 [iU]/1) + Doconexent (260 mg/1) + Folic acid (1 mg/1) + Icosapent (40 mg/1) + Iron (20 mg/1) + Linoleic acid (30 mg/1) + Pyridoxine hydrochloride (25 mg/1) + alpha-Linolenic acid (30 mg/1)	Capsule, gelatin coated	Oral	Seton Pharmaceuticals	2009-10-30	2011-11-27
Chromagen	Ferrous asparto glycinate (25 mg/1) + Ascorbic acid (60 mg/1) + Cyanocobalamin (10 ug/1) + Ferrous fumarate (50 mg/1) + Folic acid (250 ug/1) + Gastric intrinsic factor (100 mg/1) + Levomefolic acid (750 ug/1) + Zinc (12 mg/1)	Capsule	Oral	Avion Pharmaceuticals, Llc	2017-01-10	Not applicable
FeRiva FA	Ferrous asparto glycinate (36.7 mg/1) + Ascorbic acid (175 mg/1) + Biotin (300 ug/1) + Cupric oxide (1.5 mg/1) + Cyanocobalamin (12 ug/1) + Docusate sodium (50 mg/1) + Ferrous bisglycinate (36.7 mg/1) + Ferrous fumarate (36.7 mg/1) + Folic acid (1 mg/1)	Capsule, gelatin coated	Oral	Avion Pharmaceuticals, Llc	2015-01-01	Not applicable
Folcaps Omega-3	Ferrous asparto glycinate (7 mg/1) + Calcium (150 mg/1) + Calcium ascorbate dihydrate (24 mg/1) + Calcium threonate (1 mg/1) + Cholecalciferol (170 [iU]/1) + Doconexent (260 mg/1) + Folic acid (1 mg/1) + Icosapent (40 mg/1) + Iron (20 mg/1) + Pyridoxine hydrochloride (25 mg/1) + alpha-Linolenic acid (30 mg/1) + alpha-Tocopherol acetate (30 [iU]/1)	Capsule, gelatin coated	Oral	Mayne Pharma	2011-01-03	2016-12-31
Integra F	Ferrous asparto glycinate (62.5 mg/1) + Ascorbic acid (40 mg/1) + Ferrous fumarate (62.5 mg/1) + Folic acid (1 mg/1) + Niacin (3 mg/1)	Capsule	Oral	U.S. Pharmaceutical Corporation	2009-04-27	Not applicable
Integra Plus	Ferrous asparto glycinate (62.5 mg/1) + Ascorbic acid (210 mg/1) + Biotin (300 ug/1) + Ferrous fumarate (62.5 mg/1) + Folic acid (1 mg/1) + Niacin (20 mg/1) + Calcium pantothenate (5 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (5 mg/1) + Thiamine mononitrate (5 mg/1)	Capsule	Oral	U.S. Pharmaceutical Corporation	2009-04-27	Not applicable
Niferex	Ferrous asparto glycinate (50 mg/1) + Ascorbic acid (60 mg/1) + Cyanocobalamin (25 ug/1) + Folic acid (250 ug/1) + Gastric intrinsic factor (100 mg/1) + Iron Dextran (100 mg/1) + Levomefolic acid (750 ug/1) + Succinic acid (50 mg/1) + Zinc (15 mg/1)	Tablet	Oral	Avion Pharmaceuticals, Llc	2017-01-10	Not applicable
Paire OB Plus DHA	Ferrous asparto glycinate (6 mg/1) + Biotin (30 ug/1) + Cupric sulfate pentahydrate (0.8 mg/1) + Cyanocobalamin (12 ug/1) + D-alpha-Tocopherol acetate (10 [iU]/1) + Doconexent (200 mg/1) + Folic acid (1 mg/1) + Iron (22 mg/1) + Nicotinamide (17 mg/1) + Calcium pantothenate (10 mg/1) + Potassium Iodide (175 ug/1) + Pyridoxine hydrochloride (50 mg/1) + Riboflavin (1.6 mg/1) + Sodium selenate (65 ug/1) + Thiamine mononitrate (1.5 mg/1) + Vitamin D (400 [iU]/1) + Zinc oxide (15 mg/1)	Kit	Oral	Centrix Pharmaceutical	2010-10-13	2015-07-31
Prenate DHA	Ferrous asparto glycinate (18 mg/1) + Ascorbic acid (90 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (25 ug/1) + DL-alpha-Tocopherol (40 [iU]/1) + Doconexent (300 mg/1) + Folic acid (1 mg/1) + Calcium formate (155 mg/1) + Magnesium oxide (50 mg/1) + Pyridoxine hydrochloride (26 mg/1)	Capsule, gelatin coated	Oral	Avion Pharmaceuticals, Llc	2014-06-05	Not applicable
Prenate Elite	Ferrous asparto glycinate (20 mg/1) + 5-methyltetrahydrofolic acid (600 ug/1) + Ascorbic acid (75 mg/1) + Beta carotene (2600 [iU]/1) + Biotin (330 ug/1) + Cholecalciferol (600 [iU]/1) + Cupric oxide (1.5 mg/1) + Cyanocobalamin (13 ug/1) + DL-alpha tocopheryl acetate (40 [iU]/1) + Folic acid (400 ug/1) + Calcium formate (155 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (21 mg/1) + Potassium Iodide (150 ug/1) + Pyridoxine hydrochloride (21 mg/1) + Riboflavin (3.5 mg/1) + Thiamine mononitrate (3 mg/1) + Zinc oxide (15 mg/1)	Tablet, coated	Oral	Avion Pharmaceuticals, Llc	2014-06-05	Not applicable

Categories

Drug Categories

Not Available

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

H7426RGB3L

CAS number

Not Available

InChI Key

Not Available

InChI

Not Available

IUPAC Name

Not Available

SMILES

Not Available

References

General References

Not Available

External Links

PubChem Substance

347911142

RxNav

644718

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
4	Recruiting	Treatment	Iron Deficiency Anemia of Pregnancy / Iron Storage Disease	1
4	Terminated	Treatment	Anemia	1
1, 2	Unknown Status	Treatment	Postpartum Anemia	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Capsule, gelatin coated	Oral
Tablet	Oral
Capsule, liquid filled	Oral
Tablet, film coated	Oral
Tablet, coated	Oral
Kit	Oral
Capsule	Oral

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Not Available

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 03, 2015 16:51 / Updated at September 28, 2021 21:54